Yellow pages to the transcriptome

Pharmacogenomics

Volumn 3, Issue 6, 2002, Pages 791-807

  Scheel, Julia ^a   von Brevern, Marie Charlotte ^a   Hörlein, Andreas ^a   Fischer, Achim ^a   Schneider, Armin ^a   Bach, Alfred ^a  

^a Axaron Bioscience AG   (Germany)

Author keywords

DNA arrays; Fragment display; Gene expression; MPSS; Neurological diseases; Oncology; RMDD; SAGE; Toxicology; Transcriptomics

Indexed keywords

DNA; DRUG;

ALZHEIMER DISEASE; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; BIOLOGY; CANCER CLASSIFICATION; CARCINOGENESIS; CONTROLLED STUDY; DEPRESSION; DIFFERENTIAL DISPLAY; DNA HYBRIDIZATION; DNA MICROARRAY; DRUG RESEARCH; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC TRANSCRIPTION; HUMAN; IMAGE DISPLAY; MEDICAL DECISION MAKING; MOLECULAR PROBE; NEUROLOGIC DISEASE; ONCOLOGY; POLYMERASE CHAIN REACTION; PREDICTION; PROGNOSIS; RESTRICTION FRAGMENT; RESTRICTION MAPPING; REVIEW; ROBOTICS; STROKE; TECHNOLOGY; TOXICOLOGY;

ANIMALS; HUMANS; NERVOUS SYSTEM DISEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TECHNOLOGY, PHARMACEUTICAL; TRANSCRIPTION, GENETIC;

EID: 0036849112     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.3.6.791     Document Type: Review

References (100)

1. Goodman N: Biological data becomes computer literate: new advances in bioinformatics. Curr. Opin. Biotechnol. 13, 68-71 (2002).
2. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-470 (1995).
3. Yang YH, Speed T: Design issues for cDNA microarray experiments. Nat. Rev. Genet. 3, 579-588 (2002).
4. Array data go public. Nat. Genet. 22, 211-212 (1999).
5. Lockhart DJ, Dong H, Byrne MC et al.: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14, 1675-1680 (1996).
6. Ross DT Scherf U, Eisen MB et al.: Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24, 227-235 (2000).
7. Eisen MB, Brown PO: DNA arrays for analysis of gene expression. Methods Enzymol. 303, 179-205 (1999).
8. Yuen T, Wurmbach E, Pfeffer RL, Ebersole BJ, Sealfon SC: Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res. 30, e48 (2002).
9. Hughes TR, Mao M, Jones AR et al.: Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat. Biotechnol. 19, 342-347 (2001).
10. Salin H, Vujasinovic T, Mazurie A et al.: A novel sensitive microarray approach for differential screening using probes labelled with two different radioelements. Nucleic Acids Res. 30, e17 (2002).
11. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967-971 (1992).
12. Mathieu-Daude F, Welsh J, Vogt T, McClelland M: DNA rehybridization during PCR: the 'Cot effect' and its consequences. Nucleic Acids Res. 24, 2080-2086 (1996).
13. Welsh J, Chada K, Dalal SS, Cheng R, Ralph D, McClelland M: Arbitrarily primed PCR fingerprinting of RNA. Nucleic Acids Res. 20, 4965-4970 (1992).
14. Liang P: A decade of differential display. Biotechniques 33, 338-344, 346 (2002).
15. Zhang JS, Duncan EL, Chang AC, Reddel RR: Differential display of mRNA. Mol. Biotechnol. 10, 155-165 (1998).
16. Debouck C: Differential display or differential dismay? Curr. Opin. Biotechnol. 6, 597-599 (1995).
17. Malhotra K, Foltz L, Mahoney WC, Schueler PA: Interaction and effect of annealing temperature on primers used in differential display RT-PCR. Nucleic Acids Res. 26, 854-856 (1998).
18. Poirier GM, Pyati J, Wan JS, Erlander MG: Screening differentially expressed cDNA clones obtained by differential display using amplified RNA. Nucleic Acids Res. 25, 913-914 (1997).
19. Ledakis P, Tanimura H, Fojo T: Limitations of differential display. Biochem. Biophys. Res. Commun. 251, 653-656 (1998).
20. Trentmann SM, van der Knaap E, Kende H: Alternatives to 35S as a label for the differential display of eukaryotic messenger RNA. Science 267, 1186-1187 (1995).
21. Kato K: Description of the entire mRNA population by a 3′ end cDNA fragment generated by class IIS restriction enzymes. Nucleic Acids Res. 23, 3685-3690. (1995).
22. Fischer A, Saedler H, Theissen G: Restriction fragment length polymorphism-coupled domain-directed differential display: a highly efficient technique for expression analysis of multigene families. Proc. Natl. Acad. Sci. USA 92, 5331-5335 (1995).
23. Starkey MP: Expression profiling and isolation of differentially expressed genes by indexing-based differential display. Methods Mol. Biol. 175, 295-307 (2001).
24. Matz MV, Lukyanov SA: Different strategies of differential display: areas of application. Nucleic Acids Res. 26, 5537-5543 (1998).
25. Fischer A: Restriction-mediated differential display (RMDD). In: Current Protocols in Molecular Biology. Ausubel FM, Brent R, Kingston RE et al. (Eds), John Wiley & Sons 25B.24.21-25B.24.17 (Suppl. 56) (2001).
26. Prashar Y, Weissman SM: READS: a method for display of 3′-end fragments of restriction enzyme-digested cDNAs for analysis of differential gene expression. Methods Enzymol. 303, 258-272 (1999).
27. Beck S, Pohl FM: DNA sequencing with direct blotting electrophoresis. EMBO J. 3, 2905-2909 (1984).
28. Cho YJ, Meade JD, Walden JC, Chen X, Guo Z, Liang P: Multicolor fluorescent differential display. Biotechniques 30, 562-568, 570, 572 (2001).
29. Shimkets RA, Lowe DG, Tai JT et al.: Gene expression analysis by transcript profiling coupled to a gene database query. Nat. Biotechnol. 17, 798-803 (1999).
30. Sutcliffe JG, Foye PE, Erlander MG et al.: TOGA: an automated parsing technology for analyzing expression of nearly all genes. Proc. Natl. Acad. Sci. USA 97, 1976-1981 (2000).
31. Frank R, Koster H: DNA chain length markers and the influence of base composition on electrophoretic mobility of oligodeoxyribonucleotides in polyacrylamide-gels. Nucleic Acids Res. 6, 2069-2087 (1979).
32. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science 270, 484-487 (1995).
33. Brenner S, Johnson M, Bridgham J et al.: Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat. Biotechnol. 18, 630-634 (2000).
34. Velculescu VE, Zhang L, Zhou W et al.: Characterization of the yeast transcriptome. Cell 88, 243-251 (1997).
35. Powell J: SAGE. The serial analysis of gene expression. Methods Mol. Biol. 99, 297-319 (2000).
36. Scott HS, Chrast R: Global transcript expression profiling by Serial Analysis of Gene Expression (SAGE). Genet. Eng. NY 23, 201-219 (2001).
37. Yamamoto M, Wakatsuki T, Hada A, Ryo A: Use of serial analysis of gene expression (SAGE) technology. J. Immunol. Methods 250, 45-66 (2001).
38. Cheval L, Virlon B, Billon E, Aude JC, Elalouf JM, Doucet A: Large-scale analysis of gene expression: methods and application to the kidney. J. Nephrol. 15, S170-183 (2002).
39. Datson NA, van der Perk-de Jong J, van den Berg MP, de Kloet ER, Vreugdenhil E: MicroSAGE: a modified procedure for serial analysis of gene expression in limited amounts of tissue. Nucleic Acids Res. 27, 1300-1307 (1999).
40. Peters DG, Kassam AB, Yonas H, O'Hare EH, Ferrell RE, Brufsky AM: Comprehensive transcript analysis in small quantities of mRNA by SAGE-lite. Nucleic Acids Res. 27, e39 (1999).
41. Velculescu VE, Vogelstein B, Kinzler KW: Analysing uncharted transcriptomes with SAGE. Trends Genet. 16, 423-425 (2000).
42. Saha S, Sparks AB, Rago C et al.: Using the transcriptome to annotate the genome. Nat. Biotechnol. 20, 508-512 (2002).
43. Mitas M, Mikhitarian K, Hoover L et al.: Prostate-Specific Ets (PSE) factor: a novel market for detection of metastatic breast cancer in axillary lymph nodes. Br. J. Cancer 86, 899-904. (2002).
44. Byers RJ, Hoyland JA, Dixon J, Freemont AJ: Subtractive hybridization - genetic takeaways and the search for meaning. Int. J. Exp. Pathol. 81, 391-404 (2000).
45. Rockett JC, Esdaile DJ, Gibson GG: Differential gene expression in drug metabolism and toxicology: practicalities, problems and potential. Xenobiotica 29, 655-691 (1999).
46. Hubank M, Schatz DG: Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 22, 5640-5648 (1994).
47. Hubank M, Schatz DG: cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes. Methods Enzymol. 303, 325-349 (1999).
48. Diatchenko L, Lau YF, Campbell AP et al.: Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. USA 93, 6025-6030 (1996).
49. Lavery DJ, Fonjallaz P, Fleury-Olela F, Schibler U: Analysis of differential gene expression using the SABRE enrichment protocol. Methods Mol. Biol. 99, 321-345 (2000).
50. Polyak K, Riggins GJ: Gene discovery using the serial analysis of gene expression technique: implications for cancer research. J. Clin. Oncol. 19, 2948-2958 (2001).
51. Sidransky D: Emerging molecular markers of cancer. Nat. Rev. Cancer 2, 210-219 (2002).
52. van 't Veer LJ, Dai H, van de Vijver MJ et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
53. Bittner M, Meltzer P, Chen Y et al.: Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536-540 (2000).
54. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al.: Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
55. Alizadeh AA, Eisen MB, Davis RE et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511 (2000).
56. Golub TR, Slonim DK, Tamayo P et al.: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999).
57. Lin YM, Furukawa Y, Tsunoda T, Yue CT, Yang KC, Nakamura Y: Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 21, 4120-4128 (2002).
58. Leethanakul C, Patel V, Gillespie J et al.: Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19, 3220-3224 (2000).
59. Sgroi DC, Teng S, Robinson G, LeVangie R, Hudson JR, Jr., Elkahloun AG: In vivo gene expression profile analysis of human breast cancer progression. Cancer Res. 59, 5656-5661 (1999).
60. Bahn S, Augood SJ, Ryan M, Standaert DG, Starkey M, Emson PC: Gene expression profiling in the post-mortem human brain-no cause for dismay. J. Chem. Neuroanat. 22, 79-94 (2001).
61. Iscove NN, Barbara M, Gu M, Gibson M, Modi C, Winegarden N: Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA. Nat. Biotechnol. 20, 940-943. (2002).
62. Dan S, Tsunoda T, Kitahara O et al.: An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. Cancer Res. 62, 1139-1147 (2002).
63. Scherf U, Ross DT, Waltham M et al.: A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24, 236-244 (2000).
64. Staunton JE, Slonim DK, Coller HA et al.: Chemosensitivity prediction by transcriptional profiling. Proc. Natl. Acad. Sci. USA 98, 10787-10792. (2001).
65. Bonaventure P, Guo H, Tian B et al.: Nuclei and subnuclei gene expression profiling in mammalian brain. Brain Res. 943, 38-47 (2002).
66. Chow N, Cox C, Callahan LM, Weimer JM, Guo L, Coleman PD: Expression profiles of multiple genes in single neurons of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 95, 9620-9625 (1998).
67. Mariani L, McDonough WS, Hoelzinger DB et al.: Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. Cancer Res. 61, 4190-4196 (2001).
68. Zivin JA, Grotta JC: Animal stroke models. They are relevant to human disease. Stroke 21, 981-983 (1990).
69. Small DL, Buchan AM: Animal models. Br. Med. Bull. 56, 307-317 (2000).
70. Dawson T, Mandir A, Lee M: Animal models of PD. Pieces of the same puzzle? Neuron 35, 219 (2002).
71. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P: Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53-67 (2000).
72. Mimmack ML, Ryan M, Baba H et al.: Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high- susceptibility locus for schizophrenia on chromosome 22. Proc. Natl. Acad. Sci. USA 99, 4680-4685 (2002).
73. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P: Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22, 2718-2729 (2002).
74. Hakak Y, Walker JR, Li C et al.: Genomewide expression analysis reveals dysregulation of myelination- related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA 98, 4746-4751 (2001).
75. Chowdari KV, Mirnics K, Semwal P et al.: Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 11, 1373-1380 (2002).
76. Mirnics K, Middleton FA, Lewis DA, Levitt P: The human genome: gene expression profiling and schizophrenia. Am. J. Psychiatry 158, 1384 (2001).
77. Williams NM, O'Donovan MC, Owen MJ: Genome scans and microarrays: converging on genes for schizophrenia? Genome Biol. 3 (2002).
78. Trendelenburg G, Prass K, Priller J et al.: Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci. 22, 5879-5888 (2002).
79. Longa EZ, Weinstein PR, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84-91 (1989).
80. Schwarz DA, Barry G, Mackay KB et al.: Identification of differentially expressed genes induced by transient ischemic stroke. Brain Res. Mol. Brain Res. 101, 12-22 (2002).
81. Wigle D, Ho W, Lo D, Francis J, Eubanks JH, Wallace MC: Altered expression levels of SEF-2 and p112 in the rat hippocampus after transient cerebral ischemia: identification by mRNA differential display. J. Cereb. Blood Flow Metab. 19, 435-442 (1999).
82. Wrang ML, Moller F, Alsbo CW, Diemer NH: Changes in gene expression following induction of ischemic tolerance in rat brain: detection and verification. J. Neurosci. Res. 65, 54-58 (2001).
83. Keyvani K, Witte OW, Paulus W: Gene expression profiling in perilesional and contralateral areas after ischemia in rat brain. J. Cereb. Blood Flow Metab. 22, 153-160 (2002).
84. Jin K, Mao XO, Eshoo MW et al.: Microarray analysis of hippocampal gene expression in global cerebral ischemia. Ann. Neurol, 50, 93-103 (2001).
85. Soriano MA, Tessier M, Certa U, Gill R: Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia. J. Cereb. Blood Flow Metab. 20, 1045-1055 (2000).
86. Johnson DE, Wolfgang GH: Predicting human safety: screening and computational approaches. Drug Discov. Today 5, 445-454 (2000).
87. Storck T, von Brevern MC, Behrens CK, Scheel J, Bach A: Transcriptomics in predictive toxicology. Curr. Opin. Drug Discov. Devel. 5, 90-97 (2002).
88. Ulrich R, Friend SH: Toxicogenomics and drug discovery: will new technologies help us produce better drugs? Nature reviews in drug discovery. 1, 84-88 (2002).
89. Nuwaysir EF, Bittner M, Trent J, Barrett JC, Afshari CA: Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinog. 24, 153-159 (1999).
90. Bulera SJ, Eddy SM, Ferguson E et al.: RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 33, 1239-1258 (2001).
91. Burczynski ME, McMillian M, Ciervo J et al.: Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci. 58, 399-415 (2000).
92. Waring JF, Jolly RA, Ciurlionis R et al.: Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol. Appl. Pharmacol. 175, 28-42 (2001).
93. Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG: Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. 120, 359-368 (2001).
94. Thomas RS, Rank DR, Penn SG et al.: Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. 60, 1189-1194 (2001).
95. Hamadeh HK, Bushel PR, Jayadev S et al.: Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 67, 219-231 (2002).
96. Hamadeh HK, Bushel PR, Jayadev S et al.: Prediction of compound signature using high density gene expression profiling. Toxicol. Sci. 67, 232-240 (2002).
97. Yang L, Tran DK, Wang X: BADGE, Beads array for the detection of gene expression, a high-throughput diagnostic bioassay. Genome Res. 11, 1888-1898. (2001)
98. Ivanova NB, Belyavsky AV: Identification of differentially expressed genes by restriction endonuclease-based gene expression fingerprinting. Nucleic Acids Res. 23 (15), 2954-2958 (1995).
99. Prashar Y, Weissman SM: Analysis of differential gene expression by display of 3′ end restriction fragments of cDNAs. Proc. Natl. Acad. Sci. USA 93(2), 659-663 (1996).
100. Bachem CW, van der Hoeven RS, de Bruijn SM, Vreugdenhil D, Zabeau M, Visser RG: Visualization of differential gene expression using a novel method of RNA fingerprinting based on AFLP: analysis of gene expression during potato tuber development. Plant J. 9(5), 745-753 (1996).